Columbus Circle Investors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Columbus Circle Investors's NVS Position: Q4 2017 in Review
Columbus Circle Investors sold out of Novartis (NVS) in Q4 2017, closing a stake of 26,309 shares — an estimated $2.02M sold.
Columbus Circle Investors first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $24.3M in Q1 2014. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.
- Columbus Circle Investors reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
- Columbus Circle Investors sold 26,309 Novartis shares in Q4 2017, an estimated $2.02M.
- Columbus Circle Investors first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
- Columbus Circle Investors's Novartis position peaked at $24.3M in Q1 2014.
- 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.
Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.